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Concise Communication

Application of an antibiotic spectrum index in the neonatal intensive
care unit
Alexandra C. Lahart MD1

, Christopher C. McPherson PharmD1, Jeffrey S. Gerber MD, PhD2,3, Barbara B. Warner MD1,

Brian R. Lee MPH, PhD4 and Jason G. Newland MD, MEd5
1

Division of Newborn Medicine, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri, 2Division of Infectious Diseases and The
Center for Pediatric Clinical Effectiveness, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, 3Perelman School of Medicine at the University of
Pennsylvania, Philadelphia, Pennsylvania, 4Health Services and Outcomes Research, Children’s Mercy Hospital, Kansas City, Missouri and 5Division of Infectious
Diseases, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri

Abstract
Antimicrobial stewardship programs typically use days of therapy to assess antimicrobial use. However, this metric does not account for the
antimicrobial spectrum of activity. We applied an antibiotic spectrum index to a population of very-low-birth-weight infants to assess its utility
to evaluate the impact of antimicrobial stewardship interventions.
(Received 8 May 2019; accepted 6 July 2019; electronically published 29 July 2019)

Antimicrobial stewardship programs (ASPs) promote the optimal
choice, dose, duration, and route of antibiotics.1 Currently, the
Centers for Disease Control and Prevention (CDC) recommend
that ASPs measure antimicrobial use in days of therapy (DOT)
per 1,000 patient days (PD). This metric, however, does not account
for the spectrum of activity of antibiotics and, thus, may not account
for significant changes in prescribing patterns. In response, several
scoring systems to measure antibiotic spectrum have been created
and applied to different patient populations.2–4 For example, when
applied to pediatric community-acquired pneumonia, an antibiotic
spectrum index (ASI) was able to capture changes in empiric
therapy not reflected in DOT per 1,000 PD.4
Almost all very-low-birth-weight (VLBW, <1,500 g) infants in
the neonatal intensive care unit (NICU) receive antibiotics.5
Although at high risk for infection, excess antibiotic exposure in
this population has been associated with significant morbidity.6,7
Antimicrobial stewardship is challenging yet essential in the
NICU, and changes in prescribing practices may not be adequately
captured with a metric focused solely on the volume of antibiotics
exposure. The objective of this study was to apply an ASI to a
VLBW population to assess its utility in capturing changes in
multiple dimensions of antibiotic use following the implementation of NICU-specific antimicrobial stewardship interventions.
Methods
A retrospective cohort study was conducted to compare antibiotic
use for inborn VLBW infants admitted to St Louis Children’s
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Hospital NICU between January 1 and December 31, 2014, and
between January 1 and December 31, 2017. Neonates with major
congenital malformations, death, or transfer to another institution
in the first 5 days of life were excluded.
Data collection
Demographic data were collected for each patient (Table 1). All
parenteral or oral antibiotic administration during each patient’s
NICU admission was recorded. Every calendar day a patient
received 1 antibiotic equaled 1 DOT; 2 different antibiotics
received on 1 day equaled 2 DOT.8 The ASI for each antibiotic
course was calculated using the Gerber et al4 scoring system and
summed for each patient’s NICU stay. Briefly, the ASI assigns a
point for activity against 13 clinically relevant pathogens with
an additional point for activity against multidrug-resistant organisms. Antibiotic days (AD) were calculated as each calendar day a
patient received any number of antibiotics. Patient days (PD) were
recorded as the number of calendar days an infant was admitted to
the NICU. The DOT per 1,000 PD and ASI/AD values were calculated for each patient, as well as for each study year. A subgroup
analysis was performed based on 4 disease categories common
to the NICU: (1) culture proven late onset sepsis (LOS) or meningitis (2) all infections and infectious evaluations resulting in initiation of antibiotics (3) necrotizing enterocolitis (NEC) Bell’s stage
≥2 or spontaneous intestinal perforation (SIP), and (4) NEC all
stages or SIP.
Antimicrobial stewardship
Our institution implemented a prospective-audit with feedback
ASP in August 2016. Specific NICU interventions implemented
during this time included (1) changing the empiric LOS regimen
from vancomycin and gentamicin to oxacillin and gentamicin and
(2) changing the empiric NEC regimen from vancomycin,
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Table 1. Patient Demographics and Clinical Characteristics
2014
(n = 136)

2017
(n = 144)

P
Value

27 (23–34)

27 (22–35)

.68

990 (350–1,490)

950 (400–1,490)

.81

76 (55.9)

65 (45.1)

.07

Black

66 (48.5)

71 (49.3)

White

66 (48.5)

63 (44.4)

Other

4 (2.9)

9 (6.3)

Variable
Gestational age, median
wk (IQR)
Birthweight, median g (IQR)
Male gender, no. (%)
Race, no. (%)

.11

Hispanic ethnicity, no. (%)

6 (4.4)

6 (4.2)

.92

Cesarean section, no. (%)

101 (74.2)

110 (76.4)

.68

Fetus number, no. (%)

.98

Single

96 (70.6)

103 (71.5)

Twin

32 (23.5)

33 (22.9)

8 (5.9)

8 (5.6)

Triplet
Apgar 1 min, median (IQR)

4 (0–8)

3 (0–8)

.08

Apgar 5 min, median (IQR)

6 (0–9)

6 (1–9)

.38

CRIB II, median (IQR)

9 (2–17)

9 (2–21)

.76

Culture positive sepsis,
no. (%)

24 (18)

23 (16)

.75

All infections and infectious
evaluations, no. (%)

78 (57)

66 (46)

.06

Necrotizing enterocolitis
Bell's stage 2 or greater
or spontaneous intestinal
perforation, no. (%)

17 (13)

18 (13)

1

All necrotizing enterocolitis
or spontaneous intestinal
perforation, no. (%)

30 (22)

36 (25)

.58

Note. IQR, interquartile range; CRIB II, Clinical Risk Index for Babies score.

clindamycin, and gentamicin to ampicillin and gentamicin with
the addition of metronidazole for suspected perforation or necrosis
and (3) defining standard antibiotic durations for culture-negative
sepsis (5 days), Bell’s stage 1 NEC (2–3 days), Bell’s stage 2 NEC (7
days), and Bell’s stage 3 NEC (10 days).
Statistical analysis
Demographic and clinical factors for infants born in 2014 were
compared with those born in 2017 using the Mann-Whitney U test
and the Fisher exact test for continuous and categorical variables,
respectively. Total DOT per 1,000 PD and ASI/AD values for
patients born in 2014 were compared to those born in 2017 using
an unadjusted Poisson regression analysis. Statistics were performed using SPSS Statistics Grad Pack version 24.0 software
(IBM Armonk, NY) and Stata software (StataCorp version 15.1,
College Station, TX).
Results
In 2014 and 2017, 136 and 144 infants met our inclusion criteria,
respectively. No significant differences in demographics or clinical
illness indicators were observed between the 2 study years

(Table 1). All of the infants in 2014 were exposed to antibiotics during their NICU admission, while 11.8% of infants in 2017 had no
antibiotic exposure during the entire duration of their hospitalization. The total DOT per 1,000 PD was 335.6 in 2014 and
227.4 in 2017, a 32% reduction (P < .001). In addition, the total
ASI/AD decreased from 7.63 in 2014 to 5.97 in 2017 (P < .001).
Subgroup analyses demonstrated that infants with culture
proven LOS or meningitis, and those with NEC Bell’s stage 2
and above or SIP had no difference in DOT per 1,000 PD between
study years, but ASI/AD decreased significantly (P < .001) (Fig. 1).
The DOT per 1,000 PD and ASI/AD values both decreased
significantly in the LOS and all other infectious evaluations
subgroup as well as the NEC of all stages and SIP subgroup
(P < .001).
Discussion
In this single-center, retrospective study, we utilized the ASI metric
to examine an added dimension of antibiotic exposure following
antimicrobial stewardship interventions implemented in the
NICU. The significant decrease in the ASI/AD in infants with
culture confirmed infection, NEC, or SIP, whereas the DOT per
1,000 PD remained unchanged highlights the importance of the
ASI in capturing the impact of antimicrobial stewardship on the
spectrum of agents chosen despite similar use as measured by more
standard ASP metrics.
Antimicrobial stewardship metrics have historically focused on
the quantity of antibiotic used. Although quantity-based metrics
reflect some changes in prescribing practice, their inability to capture changes in spectrum has led to development of new metrics.
Madaras-Kelly et al2,3 used a Delphi approach to create a spectrum
score that was validated to demonstrate de-escalation of antimicrobial treatment in an adult healthcare system, but the scoring system
is complex. Stenehjem et al9 used a system of classifying antibiotics
into 5 categories, a simpler approach with less nuance than a
spectrum score or index.
The ASI/AD method used in our study is a simple yet detailed
and specific method of measuring spectrum of activity of antimicrobial agents. Our study highlights the need for a metric like the
ASI/AD to capture important antibiotic use improvements while
the quantity of antibiotics might remain unchanged. This metric
is likely most important in high-risk groups like VLBW infants
among whom broad-spectrum antimicrobial use has been associated with negative consequences.6,7,10
Our study has several limitations. First, this study was done at
a single institution; it might not be generalizable. Second, a
before-and-after study with only 2 time points was performed,
limiting our ability to definitively conclude that the ASP was
the driving factor in prescribing practice changes. Finally, the
ASI/AD metric does not differentiate between appropriate and
inappropriate antibiotic use or account for additional risks that
might be present in the use of certain antibiotics. For example,
the ASI does not account for differences in local microbiologic
and antibiotic susceptibility profiles, which may warrant empiric
utilization of broader-spectrum antibiotics in individual institutions. Future studies will be required to evaluate effect on microbial resistance patterns or on clinical outcomes in this high-risk
population.
In conclusion, our study has demonstrated the utility of the
ASI/AD metric in capturing changes in antibiotic use that are
not completely documented with the currently used, CDC recommended metric of DOT per 1,000 PD. We propose that the ASI/AD
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Fig. 1. Subgroup analysis by disease state of (A) days of
therapy (DOT) per 1,000 patient days (PD) and (B) antibiotic
spectrum index per antibiotic day (ASI/AD).

metric should be utilized in addition to DOT per 1,000 PD when
evaluating the impact of antimicrobial stewardship interventions.
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Conflicts of interest. All authors report no conflicts of interest relevant to this
article.

References
1. Society for Healthcare Epidemiology of America, Infectious Diseases
Society of America, Pediatric Infectious Diseases Society. Policy statement
on antimicrobial stewardship by the Society for Healthcare Epidemiology of
America (SHEA), the Infectious Diseases Society of America (IDSA), and
the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp
Epidemiol 2012;33:322–327.
2. Madaras-Kelly K, Jones M, Remington R, et al. Antimicrobial de-escalation
of treatment for healthcare-associated pneumonia within the Veterans’
Healthcare Administration. J Antimicrob Chemother 2016;71:539–546.
3. Madaras-Kelly K, Jones M, Remington R, et al. Description and validation
of a spectrum score method to measure antimicrobial de-escalation in
healthcare associated pneumonia from electronic medical records data.
BMC Infect Dis 2015;15:197.

4. Gerber JS, Hersh AL, Kronman MP, et al. Development and application of
an antibiotic spectrum index for benchmarking antibiotic selection patterns
across hospitals. Infect Control Hosp Epidemiol 2017;38:993–997.
5. Flannery DD, Ross RK, Mukhopadhyay S, et al. Temporal trends and center
variation in early antibiotic use among premature infants. JAMA Netw Open
2018;1:e180164.
6. Cotten CM, Taylor S, Stoll B, et al. Prolonged duration of initial empirical
antibiotic treatment is associated with increased rates of necrotizing
enterocolitis and death for extremely low birth weight infants. Pediatrics
2009;123:58–66.
7. Kuppala VS, Meinzen-Derr J, Morrow AL, et al. Prolonged initial empirical
antibiotic treatment is associated with adverse outcomes in premature
infants. J Pediatr 2011;159:720–725.
8. Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America
and the Society for Healthcare Epidemiology of America. Clin Infect Dis
2016;62:e51–e77.
9. Stenehjem E, Hersh AL, Sheng X, et al. Antibiotic use in small community
hospitals. Clin Infect Dis 2016;63:1273–1280.
10. Cotten CM, McDonald S, Stoll B, et al. The association of third-generation
cephalosporin use and invasive candidiasis in extremely low birth-weight
infants. Pediatrics 2006;118:717–722.

